NIH-funded research U01 cooperative agreement

Improving health outcomes for patients with inflammatory bowel disease.

Official title: RFA-DP-23-002, Improving Health Outcomes for Patients with Inflammatory Bowel Disease through Evidence-based Awareness, Referral, and Education Programs

Funded at Crohn's and Colitis Fdn of America, INC. · NIH-10895258 · Data updated 2026-11-12

This study is all about helping people with inflammatory bowel disease, like Crohn's and ulcerative colitis, get better care, especially for kids, by making sure everyone knows about the best ways to diagnose and treat these conditions, no matter their background.

More Inflammatory Bowel Disease research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionCrohn's and Colitis Fdn of America, INC.
NIH-funded
Lab location1 site (New York, United States)
Project startSeptember 30, 2023
Project endSeptember 29, 2028
Funding year2024
Award (this year)$737,676
NIH project number5U01DP006746-02
Project IDNIH-10895258 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with inflammatory bowel disease, particularly those from diverse racial and ethnic backgrounds.

Less likely to help

Patients with inflammatory bowel disease who are already receiving optimal care and have no barriers to treatment may not benefit from this research.

What this research studies

This research focuses on enhancing the health outcomes of individuals suffering from inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis. It aims to address the disparities in diagnosis and treatment among different racial and ethnic groups by implementing evidence-based awareness, referral, and education programs. The study will utilize findings from previous research to identify barriers to timely diagnosis and effective treatment, particularly for pediatric patients. By understanding and addressing social determinants of health, the research seeks to improve overall patient management and reduce complications associated with IBD.

Why it matters

Potential benefit: If successful, this research could lead to improved diagnosis and treatment for patients with inflammatory bowel disease, ultimately enhancing their quality of life.

How similar studies have gone: Previous studies have shown success in addressing health disparities in chronic diseases through targeted education and awareness programs, indicating a promising approach.

Where this research is happening

  • Crohn's and Colitis Fdn of America, INC.
    New York, United States
    Active

Researchers

  • Principal investigator: Wingate, Laura Dawn — Crohn's and Colitis Fdn of America, INC.
  • Study coordinator: Wingate, Laura Dawn

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.